GluN2B subunits are the most widespread NMDAR subunits in the adult forebrain, which is why this subunit is a key target for drug treatment of Alzheimer’s disease [20,26,27,28]. This evidence concerns the gene GRIN2B and early-onset autosomal dominant Alzheimer disease.